 |
|
Fatal Small-Bowel Necrosis and Pulmonary Hypertension in Sickle Cell Disease
Timothy G. Hammond, MBBS;
Michael W. Mosesson, MD
Arch Intern Med. 1989;149(2):447-448.
Abstract
• Initial enthusiasm for the use of vasodilators to improve pulmonary hemodynamics and symptomatic status in pulmonary hypertension of diverse etiologies has been tempered by the high incidence of serious complications, especially hypotension. However, the unrelenting hypoxia of pulmonary hypertension without treatment and the improved pulmonary hemodynamics and symptomatic states of some patients during vasodilator therapy provide the rationale for a therapeutic test of vasodilators in hemodynamically monitored patients. We report that vasodilator therapy in a patient with severe hypoxia due to pulmonary hypertension and sickle cell crisis was fatally complicated by hypotension and extensive small-bowel infarction.
(Arch Intern Med 1989;149:447-448)
Author Affiliations
From the Department of Medicine, University of Wisconsin Medical School, Milwaukee Clinical Campus, Sinai Samaritan Medical Center, Milwaukee.
Footnotes
Accepted for publication July 14, 1988.
Reprints not available.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Arginine Therapy: A New Treatment for Pulmonary Hypertension in Sickle Cell Disease?
Morris et al.
Am. J. Respir. Crit. Care Med. 2003;168:63-69.
ABSTRACT
| FULL TEXT
Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival
Castro et al.
Blood 2003;101:1257-1261.
ABSTRACT
| FULL TEXT
|
